Literature DB >> 12208603

Epitope analysis of the FanC subunit protein of the K99 (F5) fimbriae of enterotoxigenic Escherichia coli using a recombinant fusion technique.

Abiodun D Ogunniyi1, Ieva Kotlarski, Renato Morona, Paul A Manning.   

Abstract

We have used a recombinant approach to characterise the B- and T-cell epitopes of FanC, the major subunit polypeptide of K99 (F5) fimbriae of enterotoxigenic Escherichia coli strains. This involved the fusion of FanC and its carboxy-terminal truncated derivatives to a reporter, the E. coli alkaline phosphatase (PhoA), generating stable, recombinant fusions. The B-cell epitopes of FanC were characterised by Western blotting of FanC::PhoA fusion proteins with a polyclonal mouse antiserum directed against K99 fimbrial antigen, and with a panel of monoclonal antibodies generated to the K99 antigen. An attempt to characterise the T-cell epitopes of the fimbrial subunit was made by standard in vitro T-cell proliferation assay. Our results suggest that the B-cell epitopes of FanC are likely to be continuous, with a potentially immunodominant epitope at the carboxy-terminus. However, T-cell proliferation assays with the FanC::PhoA fusion proteins did not indicate any immunodominant T-cell epitope(s). We hypothesise that fusion of FanC peptides to PhoA had resulted in altered folding of the peptides for antibody and T-cell recognition, highlighting the potential problems and drawbacks of the recombinant fusion technique in defining the epitopes of certain proteins. Copyright 2002 Federation of European Microbiological Societies

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208603     DOI: 10.1111/j.1574-695X.2002.tb00599.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  1 in total

1.  Expression and immunogenicity of an Escherichia coli K99 fimbriae subunit antigen in soybean.

Authors:  Kenneth J Piller; Thomas E Clemente; Sang Mu Jun; Cynthia C Petty; Shirley Sato; David W Pascual; Kenneth L Bost
Journal:  Planta       Date:  2004-12-18       Impact factor: 4.116

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.